Inventor · disambiguated record
Olaf Peters
Also filed as: PETERS OLAF
14 granted patents·19 pending applications·84 citations·filing 2000–2014
88Inventor score
Top patents by PatentIndex Score
33 records- 0190US7378404B28β-hydrocarbyl-substituted estratrienes for use as selective estrogensSCHERING AG·Filed 2001·Granted May 27, 2008·52 cites·41 claims
- 0279US6583130B1C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compoundsSCHERING AG·Filed 2000·Granted Jun 24, 2003·18 cites·8 claims
- 0374US7427610B22-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour actionSTERIX LTD·Filed 2004·Granted Sep 23, 2008·8 cites·21 claims
- 0471US9708311B2Benzimidazole derivatives as EP4 antagonistsBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·2 cites·10 claims
- 0569US7419972B22-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1SCHERING AG·Filed 2005·Granted Sep 2, 2008·2 cites·26 claims
- 0662US7244762B2Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamatesSTERIX LTD·Filed 2004·Granted Jul 17, 2007·1 cites·24 claims
- 0761US6794409B2Use of ERβ-selective ligands for regulating fertility and compounds useful thereforSCHERING AG·Filed 2002·Granted Sep 21, 2004·1 cites·27 claims
- 0860US7732493B22-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1BAYER SCHERING PHARMA AG·Filed 2008·Granted Jun 8, 2010·0 cites·13 claims
- 0955US8492570B22-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor actionHILLISCH ALEXANDER·Filed 2008·Granted Jul 23, 2013·0 cites·5 claims
- 1054US2008182829A18Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active EstrogensPETERS OLAF·Filed 2008·Application pending·0 cites
- 1151USRE42132EAntitumoral D-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamatesSTERIX LTD·Filed 2004·Granted Feb 8, 2011·0 cites·25 claims
- 1250US7435757B22-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1SCHERING AG·Filed 2005·Granted Oct 14, 2008·0 cites·13 claims
- 1350US2003130249A1Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy)SCHERING AG·Filed 2002·Application pending·0 cites
- 1450US2005020695A1Use of ERbeta-selective ligands for regulating fertility and compounds useful thereforFiled 2004·Application pending·0 cites
- 1548US8026229B2Antitumor-active 2-alkoxyestradiol sulfamatesSTERIX LTD·Filed 2002·Granted Sep 27, 2011·0 cites·21 claims
- 1648US2009099250A1Benzocycloheptene derivatives as estrogens having selective activityWYRWA RALF·Filed 2008·Application pending·0 cites
- 1746US10730856B2Benzimidazole derivatives as EP4 ligandsBayer Pharma AG·Filed 2014·Granted Aug 4, 2020·0 cites·9 claims
- 1846US2010029598A1Extended Benzamide Derivatives as Modulators of the EP2 ReceptorBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1946US2007197488A1Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compoundsPETERS OLAF·Filed 2006·Application pending·0 cites
- 2044US2008125435A11-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioureas as modulators of the EP2 receptorBRAUER NICO·Filed 2007·Application pending·0 cites
- 2143US2009042913A1Indolylalkylthienopyrimidylamines as modulators of the EP2 receptorBRAEUER NICO·Filed 2008·Application pending·0 cites
- 2243US2009042878A1Thienopyrimidylamines as modulators of the ep2 receptorBRAEUER NICO·Filed 2008·Application pending·0 cites
- 2342US2009023738A1Diaminopyrimidines as modulators of the ep2 receptorBRAEUER NICO·Filed 2008·Application pending·0 cites
- 2442US2009029957A18-beta-substituted estratrienes as selectively active estrogensPETERS OLAF·Filed 2008·Application pending·0 cites
- 2541US7375098B28β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienesSCHERING AG·Filed 2004·Granted May 20, 2008·0 cites·19 claims
- 2641US2003171345A18Beta-substituted 11beta-aryl-estra-1,3,5,(10)-triene derivativesSCHERING AG·Filed 2002·Application pending·0 cites
- 2740US2008125463A1N-(1-hetarylpiperidin-4-yl)(het)arylamides as EP2 receptor modulatorsBRAEUER NICO·Filed 2007·Application pending·0 cites
- 2840US2005148560A1Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diolFiled 2004·Application pending·0 cites
- 2939US2007197524A1Fluorenes and carbazoles as ligands of the EP2 receptorBRAUER NICO·Filed 2006·Application pending·0 cites
- 3039US2008146576A1N-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulatorsBRAEUER NICO·Filed 2007·Application pending·0 cites
- 3138US2009023741A1Aryl/hetarylamides as modulators of the ep2 receptorBUCHMANN BERND·Filed 2008·Application pending·0 cites
- 3238US2009042882A1Substituted acetamides as modulators of the ep2 receptorBUCHMANN BERND·Filed 2008·Application pending·0 cites
- 3336US2006211670A1Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamatesHILLISCH ALEXANDER·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Olaf Peters files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →